The health ministry of UAE has started Sinopharm covid vaccine trial for children below 18 Some members of Abu Dhabi’s ruling family had participated in the trial which administered China’s Sinopharm COVID-19 vaccine to children.
Dr Nawal Al Kaabi, Chairwoman of the National Covid-19 Clinical Management Committee, who is leading the study, said: “Children are the cornerstone of any society and the future of any nation. As more and more people are vaccinated in the UAE, we want to make sure that our children are able to receive the vaccine safely.
“This is why when we designed the Sinopharm immune bridge study, we focused on ensuring all care is given to our young volunteers throughout the journey. We want both children and parents to understand every step of the process and also to know that we will be with them, supporting them, answering every question they may have, at any time.”
Dr Ahmed Deemas Alsuwaidi, Associate Professor of Paediatrics and Infectious Diseases and Chair of the Department of Pediatrics at the United Arab Emirates University, said: “With vaccines now readily available to protect against Covid-19, we are much closer to ending the pandemic.
About Sinopharm
It is a pharmaceutical company based in China, The company researches and develops, manufactures, distributes, and markets medicine and other healthcare products.
The company manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China.
